Rejnish Kumar

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Kevin J. Harrington, A. Berrier, Martin Robinson et al. · European Journal of Cancer · 2012 · 118 citations

Medicine, Oncology, Radiation Oncology +7

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Vincent Grégoire, Marc Hamoir, Changhu Chen et al. · Radiotherapy and Oncology · 2011 · 51 citations

Medicine, Oncology, Radiation Oncology +9

Oxygenated hemoglobin diffuse reflectance ratio for in vivo detection of oral pre-cancer

Rupananda J. Mallia, Shiny Sara Thomas, Anitha Mathews et al. · Journal of Biomedical Optics · 2008 · 48 citations · Full text

Natural Sciences, Biomedical Engineering, Oncology +15

Discriminant analysis of autofluorescence spectra for classification of oral lesions in vivo

J.L. Jayanthi, Rupananda J. Mallia, Sara Thomas Shiny et al. · Lasers in Surgery and Medicine · 2009 · 43 citations

Dentistry, Oncology, Oral Pathology +17

Can Dose Reduction to One Parotid Gland Prevent Xerostomia? — A Feasibility Study for Locally Advanced Head and Neck Cancer Patients Treated with Intensity-modulated Radiotherapy

Aman Anand, Jayanshu Jain, P S Negi et al. · Clinical Oncology · 2006 · 40 citations

Medicine, Oncology, Radiation Oncology +15